-transparent.png){kind=logo}
Somatostatin (SS), a physiological substance which inhibits secretion of GH, TSH, glucagon and insulin, was evaluated as a vasoactive agent. In normal and arteriopathic subjects SS was administered intravenously by bolus for 3 minutes and by infusion for 30 minutes. Rheography and plethysmography of lower limbs were performed before, during and after somatostatin administration. A marked improvement of blood flow, provoked by somatostatin, was observed. A reduction of heart rate was also observed. Some hypotheses about the mechanism with which SS acts upon peripheral circulation are discussed.
Related Publications
L Savi, and
C Cardillo, and
G Bombardieri
September 1984,
Clinical endocrinology,
L Savi, and
C Cardillo, and
G Bombardieri
January 1981,
Acta chirurgica Scandinavica,
L Savi, and
C Cardillo, and
G Bombardieri
March 1982,
Diabete & metabolisme,
L Savi, and
C Cardillo, and
G Bombardieri
January 1993,
Diabetic medicine : a journal of the British Diabetic Association,
L Savi, and
C Cardillo, and
G Bombardieri
September 1987,
Regulatory peptides,
L Savi, and
C Cardillo, and
G Bombardieri
August 1991,
Clinical science (London, England : 1979),
L Savi, and
C Cardillo, and
G Bombardieri
May 1992,
Aviation, space, and environmental medicine,
L Savi, and
C Cardillo, and
G Bombardieri
January 1976,
Progress in cardiovascular diseases,
L Savi, and
C Cardillo, and
G Bombardieri
May 1964,
Archives of neurology,
L Savi, and
C Cardillo, and
G Bombardieri
October 1979,
Diabetes,
